MedTrace Logo

Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia

NCT02526563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2019-08-05

No results posted yet for this study

Summary

The primary investigators in this study plan to investigate serum concentrations of ropivacaine in pediatric patients who already receive as standard of care a continuous wound catheter after an iliac crest alveolar bone graft harvest for completion of a previous cleft palate repair.

The goals of this study are 1) to determine serum concentrations (free, unbound) of ropivacaine 2) To evaluate pain scores during the perioperative period to determine efficacy of wound catheters for postoperative analgesia for iliac crest bone graft harvest.

Conditions

  • Alveolar Bone Grafting
  • Alveolar Cleft Grafting

Interventions

PROCEDURE

ropivicaine

Blood draws to measure serum ropivicaine

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Franklyn Cladis, MD · University of Pittsburgh

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02526563 on ClinicalTrials.gov